Zymergen researches, develops and manufactures microbes. It develops molecules for biomedical coatings and adhesives that can be used as surgical glues by first responders, such as firemen, paramedics, flight crews and others either inside the body or on the skin to close a wound or to protect against infection. The Company uses a technology platform to optimize strains in that improves economics, improves the existing production strains within existing manufacturing processes and improves the correlation between the lab and commercial manufacturing.
Type
Private
HQ
Emeryville, US
Founded
2013
Size (employees)
419 (est)+3%
Zymergen was founded in 2013 and is headquartered in Emeryville, US
Report incorrect company information

Key People/Management at Zymergen

Joshua Hoffman

Joshua Hoffman

CEO
Zach Serber

Zach Serber

Chief Science Officer and VP of Development
Jed Dean

Jed Dean

VP of Operations and Engineering
Aaron Kimball

Aaron Kimball

CTO
Tom Stephenson

Tom Stephenson

Chief Commercial Officer
Judy Gilbert

Judy Gilbert

Chief People Officer
Show more

Zymergen Office Locations

Zymergen has offices in Seattle and Emeryville
Emeryville, US (HQ)
5980 Horton St, Suite105
Seattle, US
2200 Alaskan Way
Show all (2)
Report incorrect company information

Zymergen Financials and Metrics

Summary Metrics

Founding Date

2013

Total Funding

$174.1 m

Latest funding size

$130 m

Time since last funding

2 years ago

Investors

Zymergen's latest funding round in October 2016 was reported to be $130 m. In total, Zymergen has raised $174.1 m
Show all financial metrics
Report incorrect company information

Zymergen Online and Social Media Presence

Embed Graph
Report incorrect company information